Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Microenvironment of the Pathogenesis of Cardiac Hypertrophy
Farhad Bazgir, Julia Nau, Saeideh Nakhaei‐Rad, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1780-1780
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Astragali Radix−Notoginseng Radix et Rhizoma medicine pair prevents cardiac remodeling by improving mitochondrial dynamic balance
Pingping Lin, Hong Chen, Zekun Cui, et al.
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 1, pp. 54-63
Closed Access | Times Cited: 1
Logic-based machine learning predicts how escitalopram attenuates cardiomyocyte hypertrophy
Taylor G. Eggertsen, Joshua G. Travers, Elizabeth J. Hardy, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 10
Open Access | Times Cited: 1
Large animal models of pressure overload-induced cardiac left ventricular hypertrophy to study remodelling of the human heart with aortic stenosis
Evangelia Beslika, Adelino Leite‐Moreira, León J. De Windt, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 5, pp. 461-475
Open Access | Times Cited: 6
Syringaldehyde Alleviates Cardiac Hypertrophy Induced by Hyperglycemia in H9c2 Cells Through GLP-1 Receptor Signals
Yingxiao Li, Chao-Tien Hsu, Tingting Yang, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 110-110
Open Access
Targeting senescence and GATA4 in age-related cardiovascular disease: a comprehensive approach
Mohd Imran, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Afzal, et al.
Biogerontology (2025) Vol. 26, Iss. 1
Closed Access
Heart-on-a-chip: a revolutionary organ-on-chip platform for cardiovascular disease modeling
Beiqin Liu, Shuyue Wang, Hong Ma, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Novel therapeutic insights into pathological cardiac hypertrophy: tRF-16-R29P4PE regulates PACE4 and metabolic pathways
Feng Wang, Ping Li, Xinxin Yan, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2025), pp. 119920-119920
Closed Access
17-beta estradiol prevents cardiac myocyte hypertrophy by regulating mitochondrial E3 ubiquitin ligase 1
Ximena Calle, Valeria Garrido‐Moreno, Brenda Becerra, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Baicalin Prevents Chronic β‐AR Agonist‐Induced Heart Failure via Preventing Oxidative Stress and Overactivation of the NADPH Oxidase NOX2
Yixuan Ge, En Ma, Xinxin Guo, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 4
Open Access
Ginsenoside Re Ameliorates Cardiac Hypertrophy by Regulating CaSR-Mediated Signaling Pathway
Panpan Chen, Mubo Liu, Hong Xiao, et al.
International Journal of Drug Discovery and Pharmacology (2025), pp. 100006-100006
Closed Access
Mitochondrial function: A new direction for the targeted treatment of cardiovascular diseases with Chinese herbal medicine
Lin Yang, Liang Wang, Baofeng Yang, et al.
Journal of Holistic Integrative Pharmacy (2025) Vol. 6, Iss. 1, pp. 91-104
Open Access
[The splicing factor HNRNPH1 regulates Circ-MYOCD back-splicing to modulate the course of cardiac hypertrophy].
Rui Cai, Zhuo Huang, Wenxia He, et al.
PubMed (2025) Vol. 45, Iss. 3, pp. 587-594
Closed Access
Pterostilbene attenuates heart failure by inhibiting myocardial ferroptosis through SIRT1/GSK-3β/GPX4 signaling pathway
Fan Zhang, Zhuanglin Zeng, Jiahui Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24562-e24562
Open Access | Times Cited: 4
Transcriptomic Analyses and Experimental Validation Identified Immune-Related lncRNA–mRNA Pair MIR210HG–BPIFC Regulating the Progression of Hypertrophic Cardiomyopathy
Yuan Zhang, Jiuxiao Zhao, Qiao Jin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2816-2816
Open Access | Times Cited: 3
Discrimination models with radiomics features derived from cardiovascular magnetic resonance images for distinguishing hypertensive heart disease from hypertrophic cardiomyopathy
Hongbo Zhang, Jie Tian, Chen Zhang, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 1, pp. 129-142
Open Access | Times Cited: 2
Combined Pharmacological Modulation of Translational and Transcriptional Activity Signaling Pathways as a Promising Therapeutic Approach in Children With Myocardial Changes
A. V. Каmеnshchyk, Igor Belenuchev, Valentyn Oksenych, et al.
(2024)
Open Access | Times Cited: 2
Unlocking the Potential: Angiotensin Receptor Neprilysin and Sodium Glucose Co-Transporter 2 Inhibitors for Right Ventricle Dysfunction in Heart Failure
Bibhuti B. Das
Medicina (2024) Vol. 60, Iss. 7, pp. 1112-1112
Open Access | Times Cited: 2
The synergistic protective effects of paeoniflorin and β-ecdysterone against cardiac hypertrophy through suppressing oxidative stress and ferroptosis
Peimei Yan, Xue Li, Yuhui He, et al.
Cellular Signalling (2024), pp. 111509-111509
Closed Access | Times Cited: 2
Combined Pharmacological Modulation of Translational and Transcriptional Activity Signaling Pathways as a Promising Therapeutic Approach in Children with Myocardial Changes
A. V. Каmеnshchyk, И. Ф. Беленичев, Valentyn Oksenych, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 477-477
Open Access | Times Cited: 1
Cardiac recovery from pressure overload is not altered by thyroid hormone status in old mice
Helena Kerp, Janina Gassen, Susanne Grund, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Magnoflorine attenuates Ang II-induced cardiac remodeling via promoting AMPK-regulated autophagy
Meili Zhu, Jiangbiao Hu, Yifan Pan, et al.
Cardiovascular Diagnosis and Therapy (2024) Vol. 14, Iss. 4, pp. 576-588
Open Access | Times Cited: 1
Chronic cold exposure causes left ventricular hypertrophy that appears to be physiological
McKenna P. A. Burns, Caroline R. Reges, Spencer Barnhill, et al.
Journal of Experimental Biology (2024) Vol. 227, Iss. 20
Closed Access | Times Cited: 1
Systemic inflammation is associated with myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy
Xinli Guo, Jian Zhang, Manyun Huang, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 1
Exploring PKG signaling as a therapeutic avenue for pressure overload, ischemia, and HFpEF
Saltanat Zhazykbayeva, Heidi Budde, Murat Kaçmaz, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 10, pp. 857-873
Open Access
Logic-based machine learning predicts how escitalopram inhibits cardiomyocyte hypertrophy
Taylor G. Eggertsen, Joshua G. Travers, Elizabeth J. Hardy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top